Gulf Pharmaceutical Industries (Julphar), a pharmaceutical manufacturer based in Ras Al Khaimah, launched its Dh500 million rights issue to improve its capital and debt profile. As part of its capital restructuring, which included a capital reduction of Dh503 million as an initial step, Julphar offers 500 million new shares with a nominal value of Dh1. Issued to existing shareholders, the new shares will provide investors with the same rights - ...